Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Kim

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 21, 2026
Phase-specific operative times in robotic distal pancreatectomy: impact of body mass index and learning experienceKoichi Tomita, Michael P Kim, Laura R Prakash, et al.
Journal of Strength and Conditioning Research|August 28, 2014
Caloric expenditure of aerobic, resistance, or combined high-intensity interval training using a hydraulic resistance system in healthy menPaul H Falcone, Chih-Yin Tai, Laura R Carson, et al.
Annals of Surgical Oncology|January 8, 2021
Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal AdenocarcinomaMichael G White, Andrew Lee, Diego Vicente, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 26, 2019
Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencingAndrew J Lee, Eve Simoneau, Yi-Ju Chiang, et al.
Annals of Surgical Oncology|December 13, 2018
Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic AdenocarcinomaEve Simoneau, Claire Goumard, Jeffrey E Lee, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 2, 2019
Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein ResectionLaura R Prakash, Huamin Wang, Jun Zhao, et al.
Pancreas|January 11, 2019
Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted AnalysisJordan M Cloyd, Hsiang-Chun Chen, Xuemei Wang, et al.
Surgery|May 30, 2018
Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomyJason W Denbo, Morgan Bruno, Whitney Dewhurst, et al.
Journal of Surgical Oncology|June 21, 2022
Prognostic significance of preoperative and postoperative CA 19-9 normalization in pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery firstTimothy P DiPeri, Timothy E Newhook, Laura R Prakash, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 10, 2018
Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant typeTommy Ivanics, John R Bergquist, Gang Liu, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 21, 2026
Phase-specific operative times in robotic distal pancreatectomy: impact of body mass index and learning experienceKoichi Tomita, Michael P Kim, Laura R Prakash, et al.
Journal of Strength and Conditioning Research|August 28, 2014
Caloric expenditure of aerobic, resistance, or combined high-intensity interval training using a hydraulic resistance system in healthy menPaul H Falcone, Chih-Yin Tai, Laura R Carson, et al.
Annals of Surgical Oncology|January 8, 2021
Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal AdenocarcinomaMichael G White, Andrew Lee, Diego Vicente, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 26, 2019
Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencingAndrew J Lee, Eve Simoneau, Yi-Ju Chiang, et al.
Annals of Surgical Oncology|December 13, 2018
Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic AdenocarcinomaEve Simoneau, Claire Goumard, Jeffrey E Lee, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 2, 2019
Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein ResectionLaura R Prakash, Huamin Wang, Jun Zhao, et al.
Pancreas|January 11, 2019
Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted AnalysisJordan M Cloyd, Hsiang-Chun Chen, Xuemei Wang, et al.
Surgery|May 30, 2018
Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomyJason W Denbo, Morgan Bruno, Whitney Dewhurst, et al.
Journal of Surgical Oncology|June 21, 2022
Prognostic significance of preoperative and postoperative CA 19-9 normalization in pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery firstTimothy P DiPeri, Timothy E Newhook, Laura R Prakash, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 10, 2018
Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant typeTommy Ivanics, John R Bergquist, Gang Liu, et al.
Pageof 14